South Africa expects the Food & Drug Administration to clear the release of Johnson & Johnson vaccines later this week after a contamination incident at a US plant, clearing the way for the country to ramp up its inoculation plan. “We expect that this Friday the FDA will make an announcement and we will get our J&J vaccines soon,” Health Department Director-General Sandile Buthelezi said at the Black Business Council summit in Johannesburg on Wednesday. South Africa has ordered just over 30 million of the single-dose J&J shot, enough to cover about half the population. Aspen Pharmacare Holdings Ltd., the country’s biggest drugmaker, has a contract to fill and package the vaccine at a local plant. Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.